Researchers at Tallinn University of Technology’s Department of Chemistry and Biotechnology, collaborating with scientists from the University of Helsinki and HansaBioMed Life Sciences, have undertaken a pioneering study to dissect the specific roles of different EV subtypes within the ovarian follicle. Their work shines light on how these vesicles not only carry distinct molecular cargos but also influence the supporting granulosa cells in unique ways. The granulosa cells, essential for steroid hormone production and oocyte maturation, respond differently to various EV populations, revealing a sophisticated layer of cellular regulation previously overlooked.

Previous studies frequently treated extracellular vesicles as a homogeneous population, lumping together diverse vesicle subtypes that vary substantially in size, content, and biological functions. This new research challenges that tradition by isolating small EVs, approximately 100 nanometers in diameter, and large EVs, roughly 300 nanometers, from human preovulatory follicular fluid and analyzing their distinct molecular and functional profiles. This stratification is crucial because EVs’ size often correlates with their biogenesis, cargo, and cellular effects, necessitating a more nuanced examination.

The analysis revealed striking differences in the RNA cargo of small and large vesicles. Both carry non-coding RNAs, but large EVs were particularly enriched with PIWI-interacting RNAs (piRNAs) – a specialized class of small RNAs implicated in gene regulation and genome stability, especially within reproductive tissues. Intriguingly, the role of piRNAs in granulosa cells, which are the steroidogenic support cells surrounding the egg, remains enigmatic but potentially pivotal in modulating follicular development and egg quality.

Functional assays using KGN granulosa cell lines demonstrated that small EVs broadly modulate gene expression, signal transduction pathways, and remodeling of the extracellular matrix. These multifaceted effects suggest that small EVs may have a fundamental role in maintaining follicular homeostasis and preparing the granulosa cells for their steroidogenic functions. Conversely, large EVs elicited a comparatively narrower gene expression response but significantly ramped up testosterone production, a key androgen precursor for estrogen synthesis within the ovary.

This differentiation between vesicle subtypes underscores an elaborate molecular crosstalk within the follicle, wherein EVs of varying sizes impart distinct biochemical signals to orchestrate the maturation of the egg and the hormonal milieu. As Agne Velthut-Meikas, the head of the Reproductive Biology research group and co-author of the study, notes, the follicular communication network is far more intricate than previously conceived. The identification of piRNA enrichment in large EVs points to unexplored regulatory pathways that might be crucial for fertility.

Understanding this vesicle-mediated communication gains added urgency considering factors that disrupt ovarian function, such as aging, environmental stressors, and disease states. Such disturbances in EV signaling could contribute to diminished egg quality and reduced fertility. By exploring how vesicle content and function change in pathological conditions, researchers hope to uncover biomarkers reflective of ovarian health or targets for therapeutic intervention.

One promising aspect of this research is its potential application in precision medicine for infertility. Since EVs mirror the physiological state of their cells of origin, profiling piRNA and other RNA cargoes in follicular fluid could provide a minimally invasive window into egg quality and ovarian responsiveness. This method may herald a new era where fertility treatments are tailored based on molecular signatures derived from extracellular vesicles, improving diagnostic accuracy and treatment outcomes.

Moreover, the study’s findings open avenues for further exploration into how environmental exposures – such as toxins or endocrine disruptors – might skew EV profiles and thereby influence reproductive success. By mapping these alterations, scientists could develop preventive strategies or interventions that preserve or restore healthy intercellular communication within the ovary.

The publication of this research in the esteemed Journal of Extracellular Vesicles marks a significant milestone in reproductive biology and extracellular vesicle science. It underscores the importance of dissecting EV heterogeneity to fully appreciate their biological functions, especially in vital processes like folliculogenesis and steroidogenesis. As the team continues to analyze EVs from women facing fertility challenges, their work promises insights with profound clinical implications.

In conclusion, the recognition that distinct extracellular vesicle subtypes carry unique molecular messages and exert differential effects on ovarian cells transforms our understanding of reproductive biology. This knowledge lays the groundwork for novel diagnostic and therapeutic strategies that leverage the nuanced conversation between the egg, its environment, and supporting cells, ultimately aiming to enhance female fertility and reproductive health.

Subject of Research: Human tissue samples

Article Title: Small and Large Extracellular Vesicles From Human Preovulatory Follicular Fluid Display Distinct ncRNA Cargo Profiles and Differential Effects on KGN Granulosa Cells

News Publication Date: 7-Jul-2025

Web References: http://dx.doi.org/10.1002/jev2.70119

Image Credits: Figure created by Agne Velthut-Meikas using BioRender

Keywords: extracellular vesicles, ovarian follicle, granulosa cells, piRNA, follicular fluid, egg development, steroidogenesis, fertility biomarkers, folliculogenesis, non-coding RNA, KGN cells, reproductive biology

Premature ovarian insufficiency is a condition that affects countless women worldwide, leading to hormonal imbalances and reproductive challenges. Conventional treatments typically focus on hormone replacement therapy, but these approaches may not address the underlying mechanisms contributing to POI. In contrast, the Ningxin-Tongyu-Zishen formula, rooted in centuries of herbal medicine, offers a holistic approach that warrants scientific validation. By uncovering the molecular mechanisms through which this formula influences proBDNF and mBDNF levels, the researchers aim to unveil a novel therapeutic strategy for women suffering from POI.

The balance between proBDNF and mBDNF is crucial to the health of ovarian function. While proBDNF primarily regulates cellular processes that encourage neural development, mBDNF is associated with enhancing survival and function in mature neurons, crucial for overall reproductive health. The researchers propose that disturbances in this balance may contribute to the symptoms and physiological manifestations of POI. Therefore, understanding how the Ningxin-Tongyu-Zishen formula modulates this dynamic could reveal why traditional Chinese medicine has garnered attention for treating such complex hormonal disorders.

In their research, Ma and colleagues investigated the roles of PAI-1 (plasminogen activator inhibitor-1) and tPA (tissue plasminogen activator) in the ovarian environment, where they discovered that these two proteins are modulated by the Ningxin-Tongyu-Zishen formula. Their results indicate that the formula may downregulate PAI-1 levels while promoting the activity of tPA, swinging the balance toward healthier levels of mBDNF. This biochemical shift could ultimately enhance ovarian function and thus, fertility in women facing POI.

Furthermore, the study delves into the implications of these findings on female reproductive health. With the rising incidence of premature ovarian insufficiency due to factors such as increased stress levels and environmental toxins, innovative treatments are urgently needed. The research suggests that through its influence on the PAI-1/tPA signaling pathway, the Ningxin-Tongyu-Zishen formula not only mitigates the symptoms associated with POI but potentially reverses some of the hormonal imbalances that characterize this condition.

The methodology of the study is significant and noteworthy. The researchers employed a combination of biochemical assays, animal models, and possibly genomic analysis to establish the correlation between the herbal formula’s application and the levels of proBDNF and mBDNF. This multi-faceted approach lends credibility to their findings, allowing for a comprehensive understanding of the pathways at play. It reaffirms the importance of integrating modern scientific methods with traditional herbal practices to validate and enhance their effectiveness.

The therapeutic implications of modulating the PAI-1/tPA pathway extend beyond solely the treatment of POI. Emerging evidence suggests that this pathway may play a role in various reproductive disorders, thus providing generalizability to the findings of this study. Should the results from the Ningxin-Tongyu-Zishen research translate effectively into clinical settings, they could potentially herald a new era in reproductive medicine. Future studies could expand these findings to evaluate the effectiveness of this formula across different populations and demographic groups.

In the larger context of women’s health, this research could serve as a pivotal point where traditional medicine meets modern biochemistry. It emphasizes the necessity for further research into herbal remedies, pointing toward a future where multi-faceted treatment approaches could become the norm. As scientists continue to unravel the complex signals that influence reproductive health, traditional formulas like Ningxin-Tongyu-Zishen might not only complement existing therapies but also illuminate new treatment paradigms.

The research conducted by Ma, Zhu, and Xie embodies the ongoing quest to innovate within the field of reproductive medicine. By understanding the biochemical interactions and pathways that govern reproductive health, medical professionals may someday provide women with comprehensive solutions tailored to their specific conditions. This integrative approach represents a convergence of the old and the new, ultimately aimed at improving the quality of life for countless women around the world.

Such insights also beckon deeper inquiries into the mechanisms through which other traditional herbal remedies affect reproductive health. The findings concerning Ningxin-Tongyu-Zishen could motivate more extensive research into artisanal formulations, examining their impacts on various conditions affecting women’s health. This study exemplifies how curiosity-based inquiry can lead to significant advancements in therapeutic strategies and foster a broader appreciation for ethnopharmacology.

As methodologies evolve and our understanding of intricate biological pathways expands, the potential for developing targeted treatments that respond to women’s unique health challenges becomes increasingly attainable. Researchers and medical practitioners alike have a shared responsibility to continue investigating the blends between traditional practices and contemporary science, paving the road toward innovative healthcare solutions grounded in an evidence-based approach.

In conclusion, the seminal study by Ma, Zhu, and Xie not only articulates the potential of traditional Chinese medicinal formulations in treating modern medical issues but also advocates for a holistic view of health. By emphasizing the importance of neurotrophic factors in ovarian function, the study presents a transformative narrative around premature ovarian insufficiency. This research catalyzes further exploration into the complex interplay between herbal medicine and modern biological science, fostering a sophisticated understanding of treatments that empower women facing the challenges of reproductive health. The journey ahead remains filled with promise, as we are just beginning to scratch the surface of what is possible when ancient wisdom merges with contemporary scientific inquiry.

Subject of Research: The mechanism of Ningxin-Tongyu-Zishen formula regulating probdnf/mbdnf balance through PAI-1/tPA signaling pathway in the treatment of premature ovarian insufficiency.

Article Title: The mechanism of Ningxin-Tongyu-Zishen formula regulating probdnf/mbdnf balance through PAI-1/tPA signaling pathway in the treatment of premature ovarian insufficiency.

Article References:

Ma, J., Zhu, C., Xie, L. et al. The mechanism of Ningxin-Tongyu-Zishen formula regulating probdnf/mbdnf balance through PAI-1/tPA signaling pathway in the treatment of premature ovarian insufficiency. J Ovarian Res 18, 184 (2025). https://doi.org/10.1186/s13048-025-01769-1

Image Credits: AI Generated

DOI: 10.1186/s13048-025-01769-1

Keywords: Premature ovarian insufficiency, Ningxin-Tongyu-Zishen, proBDNF, mBDNF, PAI-1, tPA, herbal medicine, reproductive health.